Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Long-Term Investments (2021 - 2023)

Select Medical Holdings (SEM) has disclosed Long-Term Investments for 3 consecutive years, with $18.4 million as the latest value for Q2 2023.

  • On a quarterly basis, Long-Term Investments changed N/A to $18.4 million in Q2 2023 year-over-year; TTM through Jun 2023 was $18.4 million, a N/A change, with the full-year FY2022 number at $45.2 million, up 150.35% from a year prior.
  • Long-Term Investments was $18.4 million for Q2 2023 at Select Medical Holdings, down from $27.0 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $45.2 million in Q4 2022 to a low of $18.1 million in Q4 2021.
  • A 3-year average of $27.2 million and a median of $22.7 million in 2023 define the central range for Long-Term Investments.
  • Biggest YoY gain for Long-Term Investments was 150.35% in 2022; the steepest drop was 150.35% in 2022.
  • Select Medical Holdings' Long-Term Investments stood at $18.1 million in 2021, then soared by 150.35% to $45.2 million in 2022, then crashed by 59.3% to $18.4 million in 2023.
  • Per Business Quant, the three most recent readings for SEM's Long-Term Investments are $18.4 million (Q2 2023), $27.0 million (Q1 2023), and $45.2 million (Q4 2022).